Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Sprout Social
SPT
$579M
| $1.29M | ﹤0.01% |
21,208
+11,286
| +114% | +$691K |
|
1477
Peabody Energy
BTU
$3.01B
| $1.29M | ﹤0.01% |
50,384
+27,599
| +121% | +$733K |
|
1478
Ultragenyx Pharmaceutical
RARE
$2.65B
| $1.29M | ﹤0.01% |
32,165
+19,234
| +149% | +$825K |
|
1479
MGE Energy Inc
MGEE
$3.07B
| $1.29M | ﹤0.01% |
16,609
+8,708
| +110% | +$631K |
|
1480
Duolingo
DUOL
$6.3B
| $1.29M | ﹤0.01% |
9,038
+5,943
| +192% | +$610K |
|
1481
Dycom Industries
DY
$12.3B
| $1.29M | ﹤0.01% |
13,755
+8,470
| +160% | +$787K |
|
|
AZEK
1482
DELISTED
The AZEK Co
AZEK
| $1.29M | ﹤0.01% |
54,690
+35,703
| +188% | +$845K |
|
1483
Vanguard Long-Term Treasury ETF
VGLT
$10.3B
| $1.29M | ﹤0.01% |
19,647
+3,953
| +25% | +$255K |
|
1484
RingCentral
RNG
$5.25B
| $1.29M | ﹤0.01% |
41,957
+25,999
| +163% | +$930K |
|
1485
Albany International
AIN
$1.81B
| $1.29M | ﹤0.01% |
14,391
+7,447
| +107% | +$751K |
|
1486
Vishay Intertechnology
VSH
$5.15B
| $1.29M | ﹤0.01% |
56,835
+31,200
| +122% | +$686K |
|
1487
VF Corp
VFC
$5.73B
| $1.28M | ﹤0.01% |
56,052
-296,650
| -84% | -$7.8M |
|
|
AEL
1488
DELISTED
American Equity Investment Life Holding Company
AEL
| $1.28M | ﹤0.01% |
35,150
+21,119
| +151% | +$898K |
|
1489
Madison Square Garden
MSGS
$9.97B
| $1.28M | ﹤0.01% |
6,561
+3,568
| +119% | +$664K |
|
|
ARNC
1490
DELISTED
Arconic Corporation
ARNC
| $1.28M | ﹤0.01% |
48,725
+31,711
| +186% | +$779K |
|
1491
Lumen
LUMN
$6.49B
| $1.28M | ﹤0.01% |
480,975
+187,626
| +64% | +$757K |
|
1492
Innovative Industrial Properties
IIPR
$1.67B
| $1.28M | ﹤0.01% |
16,800
+8,041
| +92% | +$710K |
|
1493
LXP Industrial Trust
LXP
$3.58B
| $1.27M | ﹤0.01% |
24,657
+13,376
| +119% | +$716K |
|
|
CPE
1494
DELISTED
Callon Petroleum Company
CPE
| $1.27M | ﹤0.01% |
37,994
+15,975
| +73% | +$602K |
|
1495
Ingevity
NGVT
$2.62B
| $1.27M | ﹤0.01% |
17,749
+12,541
| +241% | +$995K |
|
1496
New Fortress Energy
NFE
$94M
| $1.27M | ﹤0.01% |
43,091
+11,930
| +38% | +$421K |
|
1497
Omnicell
OMCL
$1.69B
| $1.26M | ﹤0.01% |
21,550
+13,505
| +168% | +$745K |
|
1498
Associated Banc-Corp
ASB
$6.07B
| $1.26M | ﹤0.01% |
70,194
+44,817
| +177% | +$981K |
|
1499
Unilever
UL
$133B
| $1.25M | ﹤0.01% |
21,461
+13,248
| +161% | +$753K |
|
1500
Mercury Systems
MRCY
$6.7B
| $1.25M | ﹤0.01% |
24,390
+14,946
| +158% | +$755K |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.